SIGILON THERAPEUTICS INC (SGTX)
US82657L2060 - Common Stock
| TTM (2023-3-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -37.08M | -43.56M | -77.31M | -54.61M | -43.93M | |||
| Depreciation Amortization | 1.26M | 1.26M | 1.12M | 854.00K | 680.00K | |||
| Change In Working Capital | -17.12M | -19.27M | -13.42M | -15.46M | -10.89M | |||
| Interest Paid | 2.13M | 2.00M | 1.71M | 950.00K | 550.00K | |||
| Other non cash items | 9.54M | 10.09M | 11.21M | 7.57M | 4.07M | |||
| OPERATING CASH FLOW | -43.39M | -51.47M | -78.41M | -61.65M | -50.07M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -491.00K | -537.00K | -1.83M | -972.00K | -1.21M | |||
| Other Investing Activity | 23.86M | -11.54M | -16.23M | N/A | N/A | |||
| INVESTING CASH FLOW | 23.37M | -12.08M | -18.06M | -972.00K | -1.21M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | -1.67M | 0.00 | 4.79M | 10.00M | |||
| Stock Issued/Repurchased | 38.00K | 61.00K | 1.55M | 184.84M | 53.32M | |||
| Other Financing Activity | N/A | N/A | N/A | -226.00K | -80.00K | |||
| FINANCING CASH FLOW | -3.30M | -1.61M | 1.55M | 189.40M | 63.24M | |||
| CHANGE IN CASH | -23.31M | -65.16M | -94.91M | 126.78M | 11.96M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -43.39M | -51.47M | -78.41M | -61.65M | -50.07M | |||
| Capital Expenditure | -491.00K | -537.00K | -1.83M | -972.00K | -1.21M | |||
| FREE CASH FLOW | -43.88M | -52.01M | -80.24M | -62.62M | -51.28M | |||
All data in USD